Health-Related Quality of Life Assessment and the Pharmaceutical Industry
- 1 June 1992
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 1 (6), 394-408
- https://doi.org/10.2165/00019053-199201060-00002
Abstract
Concerns about cost containment in healthcare and interest in the impact of medical treatment on patient health status and well—being have increased the emphasis on health—related quality of life...Keywords
This publication has 33 references indexed in Scilit:
- Quality of Life Instruments in the Evaluation of New DrugsPharmacoEconomics, 1992
- Principles of Pharmacoeconomic Analysis of Drug TherapyPharmacoEconomics, 1992
- Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.BMJ, 1990
- Advances in Health Status AssessmentMedical Care, 1989
- Evaluating the impact of medical treatment on the quality of life: A 5-year updateSocial Science & Medicine, 1988
- The Effects of Antihypertensive Therapy on the Quality of LifeNew England Journal of Medicine, 1986
- Assessment of quality of life in clinical trials of cardiovascular therapiesThe American Journal of Cardiology, 1984
- Cost Effectiveness of Vaccination against Pneumococcal PneumoniaNew England Journal of Medicine, 1980
- Aging, Natural Death, and the Compression of MorbidityNew England Journal of Medicine, 1980
- Studies of Illness in the AgedJAMA, 1963